世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

安定同位体標識化合物の世界市場、化合物別(炭素(13C)、窒素(15N)、重水素、酸素(18O)、その他)、用途別(診断、創薬、イメージング、滅菌、その他)、物質別(核酸、アミノ酸、医薬品/代謝物、脂肪酸/脂質、その他)、適応症別(循環器、神経、炎症、代謝性疾患、その他)、測定方法別(化学、細胞培養、その他)、エンドユーザー別(医薬品、医療機器、その他)。NMR溶媒、その他)、適応症(循環器、神経、炎症、代謝性疾患、その他)、方法(化学、細胞培養)、エンドユーザー(製薬・バイオテクノロジー企業、学術機関、その他)、地域別、2025年の予測および機会、その他


Global Stable Isotope Labeled Compounds Market, By Compounds (Carbon (13C), Nitrogen(15N), Deuterium, Oxygen(18O), Others), By Application (Diagnosis, Drug Discovery, Imaging, Sterilization, Others), By Substances (Nucleic Acids, Amino Acids, Drugs/Metabolites, Fatty Acids /Lipids, NMR Solvents and Others), By Indication (Cardiology, Neurology, Inflammation, Metabolic disease and Others), By Method (Chemical, Cell-culturing), By End-User (Pharmaceutical and Biotechnology Companies, Academic Institute and Others), By Region, Forecast & Opportunities, 2025

安定同位体標識化合物の世界市場は、予測期間中に安定した CAGR で成長すると予想されます。これらの化合物は、化学代謝中の同位体経路を確認したり、細胞内の任意の同位体の存在を検出したりするために使用され... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechSci Research
テックサイリサーチ
2022年7月1日 US$4,900
シングルユーザライセンス(印刷不可)
ライセンス・価格情報・注文方法はこちら
114 英語

 

サマリー

安定同位体標識化合物の世界市場は、予測期間中に安定した CAGR で成長すると予想されます。これらの化合物は、化学代謝中の同位体経路を確認したり、細胞内の任意の同位体の存在を検出したりするために使用されます。したがって、一般的に生物医学研究や研究開発分野で使用され、これが市場成長の主な要因となっています。癌患者の増加や製薬・バイオテクノロジー企業の増加は、市場成長の主要な要因の一つです。しかし、これらの化合物はコストが高いため購入できないことが、市場の抑制要因として働く可能性があります。
安定同位体標識化合物の世界市場は、化合物、用途、物質、適応症、手法、エンドユーザー、地域に基づいて区分されます。エンドユーザーセグメントは、さらに製薬・バイオテクノロジー企業、学術機関、その他に細分化され、このうち製薬・バイオテクノロジー企業セグメントは、これらの化合物に基づく研究の増加により、2019年に最も急速に成長すると予測される。

地域別に見ると、世界の安定同位体標識化合物市場は、アジア太平洋、ヨーロッパ、北米、南米、中東・アフリカに区分することができる。2019年現在、北米は、様々な安定同位体ベースの研究企業の存在と、それらの企業で研究開発手順を実行するのに十分な経済性を背景に、最大の市場シェアを占めています。

世界の安定同位体標識化合物市場の主要企業には、PerkinElmer、Merck、3M、Cambridge Isotope Laboratories, Inc、URENCO Limited、IsoSciences LLC、Medical Isotopes, Inc、Omicron Biochemicals, Inc、Trace Sciences International、Alsachim、大日本山荘株式会社、CortecNet、ISOFLEX、Huayi Isotopes Co, Mesbah Energy Co, C/D/N/ Isotope Inc, Shoko Co.Ltd.、Nordion Inc.、BOC Sciences、Pepscan、など。
本レポートで考慮した年数
歴史的年数:2015年~2018年
基準年:2019年
推定年:2020年
予測期間:2021-2025年
本調査の目的
- 世界の安定同位体標識化合物の市場規模を分析・予測する。
- 化合物、用途、物質、適応症、方法、エンドユーザー、地域、企業に基づいて、世界の安定同位体標識化合物市場を分類・予測する。
- 世界の安定同位体標識化合物市場の促進要因と課題を特定する。
- 世界の安定同位体標識化合物市場における拡張、新製品発表、M&Aなどの競合開発を調査する。
- 世界の安定同位体標識化合物市場の価格分析を行う。
- 世界の安定同位体標識化合物市場で活動する主要企業のプロファイルを特定し、分析する。

TechSci Research社は、本調査のために一次調査と徹底的な二次調査の両方を実施しました。最初に、TechSci Researchは世界中のメーカーのリストを入手しました。その後、TechSci Researchは特定された企業に対して一次調査アンケートを実施しました。インタビューしながら、回答者には競合他社についても質問しました。この手法により、TechSci Research は、二次調査の制限により特定できなかったメーカーを含めることができました。TechSci Researchは、世界中のすべての主要企業のメーカー、流通チャネル、存在を分析しました。
TechSci Researchは、様々なエンドユーザーセグメントのデータを記録し、将来の予測を行うボトムアップアプローチを用いて、世界の安定同位体標識化合物の市場規模を算出しました。TechSci Research社は、これらの値を業界の専門家や企業の代表者から入手し、適切で全体的な市場規模を得るためにこれらの製品タイプや用途の履歴データを分析することで外部的に検証しています。企業のウェブサイト、ニュース記事、プレスリリース、企業の年次報告書、投資家向けプレゼンテーション、財務報告書など、さまざまな二次資料もTechSci Researchによって調査されました。
主な対象読者
- 安定同位体標識化合物メーカー、サプライヤー、流通業者、その他の関係者
- バイオテクノロジーおよび製薬会社
- 規制当局や政策立案者などの政府機関
- 安定同位体標識化合物に関連する組織、フォーラム、アライアンス
- 市場調査会社、コンサルティング会社
本調査は、メーカー、パートナー、エンドユーザーなどの業界関係者にとって重要ないくつかの重要な質問に対する回答を提供し、さらに、投資戦略を立て、市場機会を活用する上で有用なものです。
レポートの範囲
本レポートでは、安定同位体標識化合物の世界市場を、以下に詳述する業界動向に加えて、以下のカテゴリーに分類しています。
- 市場、化合物別
o 炭素(13C)
o 窒素(15N)
o 重水素
o 酸素(18O)
o その他
- 市場、アプリケーション別
o 診断
o 創薬
o 画像処理
o 殺菌
o その他
- 市場、物質別
o 核酸
o アミノ酸
o 医薬品/代謝物
o 脂肪酸/脂質
o NMR溶媒
o その他
- 市場、適応症別
o 循環器
o 神経
o 炎症
o 代謝性疾患
o その他
- 市場、方法別
o 化学的手法
o 細胞培養
- 市場、エンドユーザー別
o 製薬会社、バイオテクノロジー会社
o 学術機関
o その他
- 市場、地域別
o アジア太平洋地域
中国
インド
日本
韓国
シンガポール
オーストラリア
o ヨーロッパ
フランス
ドイツ
イギリス
イタリア
ロシア
スペイン
o 北米
米国
メキシコ
カナダ
o 南アメリカ
ブラジル
アルゼンチン
コロンビア
o 中東・アフリカ
南アフリカ
サウジアラビア
UAE

競合他社の状況
企業プロファイル。世界の安定同位体標識化合物市場における主要企業の詳細分析。
利用可能なカスタマイズ。
TechSci Researchでは、与えられた市場データをもとに、企業の特定のニーズに応じたカスタマイズを提供しています。このレポートでは、以下のカスタマイズが可能です。
企業情報
- 追加的な市場プレイヤーの詳細分析とプロファイリング(最大5社)。

ページTOPに戻る


目次

1. Product Overview
2. Research Methodology
3. Executive Summary
4. Voice of Customer
5. Global Stable Isotopes Labeled Compounds Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value & Volume
5.2. Market Share & Forecast
5.2.1. By Compounds (Carbon (13C), Nitrogen(15N), Deuterium, Oxygen(18O), Others)
5.2.2. By Application (Diagnosis, Drug Discovery, Imaging, Sterilization, Others)
5.2.3. By Substances (Nucleic Acids, Amino Acids, Drugs/Metabolites, Fatty Acids /Lipids. NMR Solvents and Others)
5.2.4. By Indication (Cardiology, Neurology, Inflammation, Metabolic disease and Others)
5.2.5. By Method (Chemical, Cell-culturing)
5.2.6. By End-User (Pharmaceutical and Biotechnology Companies, Academic Institute and Others)
5.2.7. By Company (2019)
5.2.8. By Region
5.3. Market Attractiveness Index
6. Asia-Pacific Stable Isotopes Labeled Compounds Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Compounds
6.2.2. By Application
6.2.3. By Substances
6.2.4. By Indication
6.2.5. By Method
6.2.6. By End-User
6.2.7. By Country
6.3. Market Attractiveness Index
6.4. Asia-Pacific: Country Analysis
6.4.1. China Stable Isotopes Labeled Compounds Market Outlook
6.4.1.1. Market Size & Forecast
6.4.1.1.1. By Value
6.4.1.2. Market Share & Forecast
6.4.1.2.1. By Compounds
6.4.1.2.2. By Application
6.4.1.2.3. By Substances
6.4.1.2.4. By Indication
6.4.1.2.5. By Method
6.4.1.2.6. By End-User
6.4.2. India Stable Isotopes Labeled Compounds Market Outlook
6.4.2.1. Market Size & Forecast
6.4.2.1.1. By Value
6.4.2.2. Market Share & Forecast
6.4.2.2.1. By Compounds
6.4.2.2.2. By Application
6.4.2.2.3. By Substances
6.4.2.2.4. By Indication
6.4.2.2.5. By Method
6.4.2.2.6. By End-User
6.4.3. Japan Stable Isotopes Labeled Compounds Market Outlook
6.4.3.1. Market Size & Forecast
6.4.3.1.1. By Value
6.4.3.2. Market Share & Forecast
6.4.3.2.1. By Compounds
6.4.3.2.2. By Application
6.4.3.2.3. By Substances
6.4.3.2.4. By Indication
6.4.3.2.5. By Method
6.4.3.2.6. By End-User
6.4.4. South Korea Stable Isotopes Labeled Compounds Market Outlook
6.4.4.1. Market Size & Forecast
6.4.4.1.1. By Value
6.4.4.2. Market Share & Forecast
6.4.4.2.1. By Compounds
6.4.4.2.2. By Application
6.4.4.2.3. By Substances
6.4.4.2.4. By Indication
6.4.4.2.5. By Method
6.4.4.2.6. By End-User
6.4.5. Singapore Stable Isotopes Labeled Compounds Market Outlook
6.4.5.1. Market Size & Forecast
6.4.5.1.1. By Value
6.4.5.2. Market Share & Forecast
6.4.5.2.1. By Compounds
6.4.5.2.2. By Application
6.4.5.2.3. By Substances
6.4.5.2.4. By Indication
6.4.5.2.5. By Method
6.4.5.2.6. By End-User
6.4.6. Australia Stable Isotopes Labeled Compounds Market Outlook
6.4.6.1. Market Size & Forecast
6.4.6.1.1. By Value
6.4.6.2. Market Share & Forecast
6.4.6.2.1. By Compounds
6.4.6.2.2. By Application
6.4.6.2.3. By Substances
6.4.6.2.4. By Indication
6.4.6.2.5. By Method
6.4.6.2.6. By End-User
7. Europe Stable Isotopes Labeled Compounds Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Compounds
7.2.2. By Application
7.2.3. By Substances
7.2.4. By Indication
7.2.5. By Method
7.2.6. By End-User
7.2.7. By Country
7.3. Market Attractiveness Index
7.4. Europe: Country Analysis
7.4.1. France Stable Isotopes Labeled Compounds Market Outlook
7.4.1.1. Market Size & Forecast
7.4.1.1.1. By Value
7.4.1.2. Market Share & Forecast
7.4.1.2.1. By Product
7.4.1.2.2. By Compounds
7.4.1.2.3. By Application
7.4.1.2.4. By Substances
7.4.1.2.5. By Indication
7.4.1.2.6. By Method
7.4.1.2.7. By End-User
7.4.2. Germany Stable Isotopes Labeled Compounds Market Outlook
7.4.2.1. Market Size & Forecast
7.4.2.1.1. By Value
7.4.2.2. Market Share & Forecast
7.4.2.2.1. By Compounds
7.4.2.2.2. By Application
7.4.2.2.3. By Substances
7.4.2.2.4. By Indication
7.4.2.2.5. By Method
7.4.2.2.6. By End-User
7.4.3. United Kingdom Stable Isotopes Labeled Compounds Market Outlook
7.4.3.1. Market Size & Forecast
7.4.3.1.1. By Value
7.4.3.2. Market Share & Forecast
7.4.3.2.1. By Compounds
7.4.3.2.2. By Application
7.4.3.2.3. By Substances
7.4.3.2.4. By Indication
7.4.3.2.5. By Method
7.4.3.2.6. By End-User
7.4.4. Italy Stable Isotopes Labeled Compounds Market Outlook
7.4.4.1. Market Size & Forecast
7.4.4.1.1. By Value
7.4.4.2. Market Share & Forecast
7.4.4.2.1. By Compounds
7.4.4.2.2. By Application
7.4.4.2.3. By Substances
7.4.4.2.4. By Indication
7.4.4.2.5. By Method
7.4.4.2.6. By End-User
7.4.5. Russia Stable Isotopes Labeled Compounds Market Outlook
7.4.5.1. Market Size & Forecast
7.4.5.1.1. By Value
7.4.5.2. Market Share & Forecast
7.4.5.2.1. By Compounds
7.4.5.2.2. By Application
7.4.5.2.3. By Substances
7.4.5.2.4. By Indication
7.4.5.2.5. By Method
7.4.5.2.6. By End-User
7.4.6. Spain Stable Isotopes Labeled Compounds Market Outlook
7.4.6.1. Market Size & Forecast
7.4.6.1.1. By Value
7.4.6.2. Market Share & Forecast
7.4.6.2.1. By Compounds
7.4.6.2.2. By Application
7.4.6.2.3. By Substances
7.4.6.2.4. By Indication
7.4.6.2.5. By Method
7.4.6.2.6. By End-User
8. North America Stable Isotopes Labeled Compounds Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Compounds
8.2.2. By Application
8.2.3. By Substances
8.2.4. By Indication
8.2.5. By Method
8.2.6. By End-User
8.2.7. By Country
8.3. Market Attractiveness Index
8.4. North America: Country Analysis
8.4.1. United States Stable Isotopes Labeled Compounds Market Outlook
8.4.1.1. Market Size & Forecast
8.4.1.1.1. By Value
8.4.1.2. Market Share & Forecast
8.4.1.2.1. By Compounds
8.4.1.2.2. By Application
8.4.1.2.3. By Substances
8.4.1.2.4. By Indication
8.4.1.2.5. By Method
8.4.1.2.6. By End-User
8.4.2. Mexico Stable Isotopes Labeled Compounds Market Outlook
8.4.2.1. Market Size & Forecast
8.4.2.1.1. By Value
8.4.2.2. Market Share & Forecast
8.4.2.2.1. By Compounds
8.4.2.2.2. By Application
8.4.2.2.3. By Substances
8.4.2.2.4. By Indication
8.4.2.2.5. By Method
8.4.2.2.6. By End-User
8.4.3. Canada Stable Isotopes Labeled Compounds Market Outlook
8.4.3.1. Market Size & Forecast
8.4.3.1.1. By Value
8.4.3.2. Market Share & Forecast
8.4.3.2.1. By Compounds
8.4.3.2.2. By Application
8.4.3.2.3. By Substances
8.4.3.2.4. By Indication
8.4.3.2.5. By Method
8.4.3.2.6. By End-User
9. South America Stable Isotopes Labeled Compounds Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Compounds
9.2.2. By Application
9.2.3. By Substances
9.2.4. By Indication
9.2.5. By Method
9.2.6. By End-User
9.2.7. By Country
9.3. Market Attractiveness Index
9.4. South America: Country Analysis
9.4.1. Brazil Stable Isotopes Labeled Compounds Market Outlook
9.4.1.1. Market Size & Forecast
9.4.1.1.1. By Value
9.4.1.2. Market Share & Forecast
9.4.1.2.1. By Compounds
9.4.1.2.2. By Application
9.4.1.2.3. By Substances
9.4.1.2.4. By Indication
9.4.1.2.5. By Method
9.4.1.2.6. By End-User
9.4.2. Argentina Stable Isotopes Labeled Compounds Market Outlook
9.4.2.1. Market Size & Forecast
9.4.2.1.1. By Value
9.4.2.2. Market Share & Forecast
9.4.2.2.1. By Compounds
9.4.2.2.2. By Application
9.4.2.2.3. By Substances
9.4.2.2.4. By Indication
9.4.2.2.5. By Method
9.4.2.2.6. By End-User
9.4.3. Colombia Stable Isotopes Labeled Compounds Market Outlook
9.4.3.1. Market Size & Forecast
9.4.3.1.1. By Value
9.4.3.2. Market Share & Forecast
9.4.3.2.1. By Compounds
9.4.3.2.2. By Application
9.4.3.2.3. By Substances
9.4.3.2.4. By Indication
9.4.3.2.5. By Method
9.4.3.2.6. By End-User
10. Middle East and Africa Stable Isotopes Labeled Compounds Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Compounds
10.2.2. By Application
10.2.3. By Substances
10.2.4. By Indication
10.2.5. By Method
10.2.6. By End-User
10.2.7. By Country
10.3. Market Attractiveness Index
10.4. MEA: Country Analysis
10.4.1. South Africa Stable Isotopes Labeled Compounds Market Outlook
10.4.1.1. Market Size & Forecast
10.4.1.1.1. By Value
10.4.1.2. Market Share & Forecast
10.4.1.2.1. By Compounds
10.4.1.2.2. By Application
10.4.1.2.3. By Substances
10.4.1.2.4. By Indication
10.4.1.2.5. By Method
10.4.1.2.6. By End-User
10.4.2. Saudi Arabia Stable Isotopes Labeled Compounds Market Outlook
10.4.2.1. Market Size & Forecast
10.4.2.1.1. By Value
10.4.2.2. Market Share & Forecast
10.4.2.2.1. By Compounds
10.4.2.2.2. By Application
10.4.2.2.3. By Substances
10.4.2.2.4. By Indication
10.4.2.2.5. By Method
10.4.2.2.6. By End-User
10.4.3. UAE Stable Isotopes Labeled Compounds Market Outlook
10.4.3.1. Market Size & Forecast
10.4.3.1.1. By Value
10.4.3.2. Market Share & Forecast
10.4.3.2.1. By Compounds
10.4.3.2.2. By Application
10.4.3.2.3. By Substances
10.4.3.2.4. By Indication
10.4.3.2.5. By Method
10.4.3.2.6. By End-User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
13. Competitive Landscape
13.1. Competition Outlook
13.2. Players Profiled (Leading Companies)
13.2.1. PerkinElmer
13.2.2. Merck
13.2.3. 3M
13.2.4. Cambridge Isotope Laboratories, Inc.
13.2.5. URENCO Limited
13.2.6. IsoSciences, LLC
13.2.7. Medical Isotopes, Inc.
13.2.8. Omicron Biochemicals, Inc.
13.2.9. Trace Sciences International
13.2.10. Alsachim
13.2.11. Taiyo Nippon Sanso Corporation
13.2.12. CortecNet
13.2.13. ISOFLEX
13.2.14. Huayi Isotopes Co
13.2.15. Mesbah Energy Co.
13.2.16. C/D/N/ Isotope Inc.
13.2.17. Shoko Co. Ltd.
13.2.18. Nordion Inc.
13.2.19. BOC Sciences
13.2.20. Pepscan
14. Strategic Recommendations
15. About Us & Disclaimer

 

ページTOPに戻る


 

Summary

The global market for stable isotope labeled compounds is expected to grow at a steady CAGR during the forecast period. These compounds are used to check the isotope pathway during a chemical metabolism or to detect any isotopic presence in the cells. Thus, they are generally used in biomedical research and the R&D sector, which is a major factor contributing to the growth of the market. The rising cancer cases and the increasing number of pharma and biotech companies is one of the major factors for the market growth. However, the inability to buy these compounds due to their costliness is a reason which might act as a restraint to the market.
The global stable isotope labeled compounds market is segmented based on compounds, application, substances, indication, method, end-user and region. The end-user segment is further fragmented into pharmaceutical and biotechnology companies, academic institute and others, out of which pharmaceutical and biotechnology companies segment is expected to be the fastest growing segment in 2019, due to the increasing researches based on these compounds.

Based on region, global stable isotope labeled compounds market can be segmented into Asia-Pacific, Europe, North America, South America, and Middle East & Africa. As of 2019, North America held the largest market share on the back of the presence of various stable isotope-based research companies and an economy good enough to carry out the R&D procedures in those companies.

Major players of the global stable isotope labeled compounds market include PerkinElmer, Merck, 3M, Cambridge Isotope Laboratories, Inc., URENCO Limited, IsoSciences LLC, Medical Isotopes, Inc., Omicron Biochemicals, Inc., Trace Sciences International, Alsachim, Taiyo Nippon Sanso Corporation, CortecNet, ISOFLEX, Huayi Isotopes Co., Mesbah Energy Co., C/D/N/ Isotope Inc., Shoko Co. Ltd., Nordion Inc., BOC Sciences, Pepscan, etc.
Years considered for this report:
Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021–2025
Objective of the Study:
• To analyze and forecast the market size of global stable isotope labeled compounds market.
• To classify and forecast global stable isotope labeled compounds market based on compounds, application, substances, indication, method, end-user, region and company.
• To identify drivers and challenges for global stable isotope labeled compounds market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global stable isotope labeled compounds market.
• To conduct pricing analysis for global stable isotope labeled compounds market.
• To identify and analyze the profile of leading players operating in global stable isotope labeled compounds market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.
TechSci Research calculated the market size of global stable isotope labeled compounds market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
• Stable isotope labeled compounds manufacturers, suppliers, distributors and other stakeholders
• Biotechnology and pharma companies
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to stable isotope labeled compounds
• Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, global stable isotope labeled compounds market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Market, By Compounds:
o Carbon (13C)
o Nitrogen(15N)
o Deuterium
o Oxygen(18O)
o Others
• Market, By Application:
o Diagnosis
o Drug Discovery
o Imaging
o Sterilization
o Others
• Market, By Substances:
o Nucleic Acids
o Amino Acids
o Drugs/Metabolites
o Fatty Acids/Lipids
o NMR Solvents
o Others
• Market, By Indication:
o Cardiology
o Neurology
o Inflammation
o Metabolic disease
o Others
• Market, By Method:
o Chemical
o Cell-culturing
• Market, By End-User:
o Pharmaceutical and Biotechnology Companies
o Academic Institute
o Others
• Market, By Region:
o Asia-Pacific
 China
 India
 Japan
 South Korea
 Singapore
 Australia
o Europe
 France
 Germany
 United Kingdom
 Italy
 Russia
 Spain
o North America
 United States
 Mexico
 Canada
o South America
 Brazil
 Argentina
 Colombia
o Middle east & Africa
 South Africa
 Saudi Arabia
 UAE

Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global stable isotope labeled compounds market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).



ページTOPに戻る


Table of Contents

1. Product Overview
2. Research Methodology
3. Executive Summary
4. Voice of Customer
5. Global Stable Isotopes Labeled Compounds Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value & Volume
5.2. Market Share & Forecast
5.2.1. By Compounds (Carbon (13C), Nitrogen(15N), Deuterium, Oxygen(18O), Others)
5.2.2. By Application (Diagnosis, Drug Discovery, Imaging, Sterilization, Others)
5.2.3. By Substances (Nucleic Acids, Amino Acids, Drugs/Metabolites, Fatty Acids /Lipids. NMR Solvents and Others)
5.2.4. By Indication (Cardiology, Neurology, Inflammation, Metabolic disease and Others)
5.2.5. By Method (Chemical, Cell-culturing)
5.2.6. By End-User (Pharmaceutical and Biotechnology Companies, Academic Institute and Others)
5.2.7. By Company (2019)
5.2.8. By Region
5.3. Market Attractiveness Index
6. Asia-Pacific Stable Isotopes Labeled Compounds Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Compounds
6.2.2. By Application
6.2.3. By Substances
6.2.4. By Indication
6.2.5. By Method
6.2.6. By End-User
6.2.7. By Country
6.3. Market Attractiveness Index
6.4. Asia-Pacific: Country Analysis
6.4.1. China Stable Isotopes Labeled Compounds Market Outlook
6.4.1.1. Market Size & Forecast
6.4.1.1.1. By Value
6.4.1.2. Market Share & Forecast
6.4.1.2.1. By Compounds
6.4.1.2.2. By Application
6.4.1.2.3. By Substances
6.4.1.2.4. By Indication
6.4.1.2.5. By Method
6.4.1.2.6. By End-User
6.4.2. India Stable Isotopes Labeled Compounds Market Outlook
6.4.2.1. Market Size & Forecast
6.4.2.1.1. By Value
6.4.2.2. Market Share & Forecast
6.4.2.2.1. By Compounds
6.4.2.2.2. By Application
6.4.2.2.3. By Substances
6.4.2.2.4. By Indication
6.4.2.2.5. By Method
6.4.2.2.6. By End-User
6.4.3. Japan Stable Isotopes Labeled Compounds Market Outlook
6.4.3.1. Market Size & Forecast
6.4.3.1.1. By Value
6.4.3.2. Market Share & Forecast
6.4.3.2.1. By Compounds
6.4.3.2.2. By Application
6.4.3.2.3. By Substances
6.4.3.2.4. By Indication
6.4.3.2.5. By Method
6.4.3.2.6. By End-User
6.4.4. South Korea Stable Isotopes Labeled Compounds Market Outlook
6.4.4.1. Market Size & Forecast
6.4.4.1.1. By Value
6.4.4.2. Market Share & Forecast
6.4.4.2.1. By Compounds
6.4.4.2.2. By Application
6.4.4.2.3. By Substances
6.4.4.2.4. By Indication
6.4.4.2.5. By Method
6.4.4.2.6. By End-User
6.4.5. Singapore Stable Isotopes Labeled Compounds Market Outlook
6.4.5.1. Market Size & Forecast
6.4.5.1.1. By Value
6.4.5.2. Market Share & Forecast
6.4.5.2.1. By Compounds
6.4.5.2.2. By Application
6.4.5.2.3. By Substances
6.4.5.2.4. By Indication
6.4.5.2.5. By Method
6.4.5.2.6. By End-User
6.4.6. Australia Stable Isotopes Labeled Compounds Market Outlook
6.4.6.1. Market Size & Forecast
6.4.6.1.1. By Value
6.4.6.2. Market Share & Forecast
6.4.6.2.1. By Compounds
6.4.6.2.2. By Application
6.4.6.2.3. By Substances
6.4.6.2.4. By Indication
6.4.6.2.5. By Method
6.4.6.2.6. By End-User
7. Europe Stable Isotopes Labeled Compounds Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Compounds
7.2.2. By Application
7.2.3. By Substances
7.2.4. By Indication
7.2.5. By Method
7.2.6. By End-User
7.2.7. By Country
7.3. Market Attractiveness Index
7.4. Europe: Country Analysis
7.4.1. France Stable Isotopes Labeled Compounds Market Outlook
7.4.1.1. Market Size & Forecast
7.4.1.1.1. By Value
7.4.1.2. Market Share & Forecast
7.4.1.2.1. By Product
7.4.1.2.2. By Compounds
7.4.1.2.3. By Application
7.4.1.2.4. By Substances
7.4.1.2.5. By Indication
7.4.1.2.6. By Method
7.4.1.2.7. By End-User
7.4.2. Germany Stable Isotopes Labeled Compounds Market Outlook
7.4.2.1. Market Size & Forecast
7.4.2.1.1. By Value
7.4.2.2. Market Share & Forecast
7.4.2.2.1. By Compounds
7.4.2.2.2. By Application
7.4.2.2.3. By Substances
7.4.2.2.4. By Indication
7.4.2.2.5. By Method
7.4.2.2.6. By End-User
7.4.3. United Kingdom Stable Isotopes Labeled Compounds Market Outlook
7.4.3.1. Market Size & Forecast
7.4.3.1.1. By Value
7.4.3.2. Market Share & Forecast
7.4.3.2.1. By Compounds
7.4.3.2.2. By Application
7.4.3.2.3. By Substances
7.4.3.2.4. By Indication
7.4.3.2.5. By Method
7.4.3.2.6. By End-User
7.4.4. Italy Stable Isotopes Labeled Compounds Market Outlook
7.4.4.1. Market Size & Forecast
7.4.4.1.1. By Value
7.4.4.2. Market Share & Forecast
7.4.4.2.1. By Compounds
7.4.4.2.2. By Application
7.4.4.2.3. By Substances
7.4.4.2.4. By Indication
7.4.4.2.5. By Method
7.4.4.2.6. By End-User
7.4.5. Russia Stable Isotopes Labeled Compounds Market Outlook
7.4.5.1. Market Size & Forecast
7.4.5.1.1. By Value
7.4.5.2. Market Share & Forecast
7.4.5.2.1. By Compounds
7.4.5.2.2. By Application
7.4.5.2.3. By Substances
7.4.5.2.4. By Indication
7.4.5.2.5. By Method
7.4.5.2.6. By End-User
7.4.6. Spain Stable Isotopes Labeled Compounds Market Outlook
7.4.6.1. Market Size & Forecast
7.4.6.1.1. By Value
7.4.6.2. Market Share & Forecast
7.4.6.2.1. By Compounds
7.4.6.2.2. By Application
7.4.6.2.3. By Substances
7.4.6.2.4. By Indication
7.4.6.2.5. By Method
7.4.6.2.6. By End-User
8. North America Stable Isotopes Labeled Compounds Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Compounds
8.2.2. By Application
8.2.3. By Substances
8.2.4. By Indication
8.2.5. By Method
8.2.6. By End-User
8.2.7. By Country
8.3. Market Attractiveness Index
8.4. North America: Country Analysis
8.4.1. United States Stable Isotopes Labeled Compounds Market Outlook
8.4.1.1. Market Size & Forecast
8.4.1.1.1. By Value
8.4.1.2. Market Share & Forecast
8.4.1.2.1. By Compounds
8.4.1.2.2. By Application
8.4.1.2.3. By Substances
8.4.1.2.4. By Indication
8.4.1.2.5. By Method
8.4.1.2.6. By End-User
8.4.2. Mexico Stable Isotopes Labeled Compounds Market Outlook
8.4.2.1. Market Size & Forecast
8.4.2.1.1. By Value
8.4.2.2. Market Share & Forecast
8.4.2.2.1. By Compounds
8.4.2.2.2. By Application
8.4.2.2.3. By Substances
8.4.2.2.4. By Indication
8.4.2.2.5. By Method
8.4.2.2.6. By End-User
8.4.3. Canada Stable Isotopes Labeled Compounds Market Outlook
8.4.3.1. Market Size & Forecast
8.4.3.1.1. By Value
8.4.3.2. Market Share & Forecast
8.4.3.2.1. By Compounds
8.4.3.2.2. By Application
8.4.3.2.3. By Substances
8.4.3.2.4. By Indication
8.4.3.2.5. By Method
8.4.3.2.6. By End-User
9. South America Stable Isotopes Labeled Compounds Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Compounds
9.2.2. By Application
9.2.3. By Substances
9.2.4. By Indication
9.2.5. By Method
9.2.6. By End-User
9.2.7. By Country
9.3. Market Attractiveness Index
9.4. South America: Country Analysis
9.4.1. Brazil Stable Isotopes Labeled Compounds Market Outlook
9.4.1.1. Market Size & Forecast
9.4.1.1.1. By Value
9.4.1.2. Market Share & Forecast
9.4.1.2.1. By Compounds
9.4.1.2.2. By Application
9.4.1.2.3. By Substances
9.4.1.2.4. By Indication
9.4.1.2.5. By Method
9.4.1.2.6. By End-User
9.4.2. Argentina Stable Isotopes Labeled Compounds Market Outlook
9.4.2.1. Market Size & Forecast
9.4.2.1.1. By Value
9.4.2.2. Market Share & Forecast
9.4.2.2.1. By Compounds
9.4.2.2.2. By Application
9.4.2.2.3. By Substances
9.4.2.2.4. By Indication
9.4.2.2.5. By Method
9.4.2.2.6. By End-User
9.4.3. Colombia Stable Isotopes Labeled Compounds Market Outlook
9.4.3.1. Market Size & Forecast
9.4.3.1.1. By Value
9.4.3.2. Market Share & Forecast
9.4.3.2.1. By Compounds
9.4.3.2.2. By Application
9.4.3.2.3. By Substances
9.4.3.2.4. By Indication
9.4.3.2.5. By Method
9.4.3.2.6. By End-User
10. Middle East and Africa Stable Isotopes Labeled Compounds Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Compounds
10.2.2. By Application
10.2.3. By Substances
10.2.4. By Indication
10.2.5. By Method
10.2.6. By End-User
10.2.7. By Country
10.3. Market Attractiveness Index
10.4. MEA: Country Analysis
10.4.1. South Africa Stable Isotopes Labeled Compounds Market Outlook
10.4.1.1. Market Size & Forecast
10.4.1.1.1. By Value
10.4.1.2. Market Share & Forecast
10.4.1.2.1. By Compounds
10.4.1.2.2. By Application
10.4.1.2.3. By Substances
10.4.1.2.4. By Indication
10.4.1.2.5. By Method
10.4.1.2.6. By End-User
10.4.2. Saudi Arabia Stable Isotopes Labeled Compounds Market Outlook
10.4.2.1. Market Size & Forecast
10.4.2.1.1. By Value
10.4.2.2. Market Share & Forecast
10.4.2.2.1. By Compounds
10.4.2.2.2. By Application
10.4.2.2.3. By Substances
10.4.2.2.4. By Indication
10.4.2.2.5. By Method
10.4.2.2.6. By End-User
10.4.3. UAE Stable Isotopes Labeled Compounds Market Outlook
10.4.3.1. Market Size & Forecast
10.4.3.1.1. By Value
10.4.3.2. Market Share & Forecast
10.4.3.2.1. By Compounds
10.4.3.2.2. By Application
10.4.3.2.3. By Substances
10.4.3.2.4. By Indication
10.4.3.2.5. By Method
10.4.3.2.6. By End-User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
13. Competitive Landscape
13.1. Competition Outlook
13.2. Players Profiled (Leading Companies)
13.2.1. PerkinElmer
13.2.2. Merck
13.2.3. 3M
13.2.4. Cambridge Isotope Laboratories, Inc.
13.2.5. URENCO Limited
13.2.6. IsoSciences, LLC
13.2.7. Medical Isotopes, Inc.
13.2.8. Omicron Biochemicals, Inc.
13.2.9. Trace Sciences International
13.2.10. Alsachim
13.2.11. Taiyo Nippon Sanso Corporation
13.2.12. CortecNet
13.2.13. ISOFLEX
13.2.14. Huayi Isotopes Co
13.2.15. Mesbah Energy Co.
13.2.16. C/D/N/ Isotope Inc.
13.2.17. Shoko Co. Ltd.
13.2.18. Nordion Inc.
13.2.19. BOC Sciences
13.2.20. Pepscan
14. Strategic Recommendations
15. About Us & Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(バイオ薬物)の最新刊レポート

TechSci Research 社の最新刊レポート

本レポートと同じKEY WORD(biotechnology)の最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/07/05 10:26

162.17 円

175.82 円

209.73 円

ページTOPに戻る